<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

qz
AstraZeneca stock sinks on reports of merger talks with Bristol Myers Squibb

A combination of the two pharmaceutical companies could create an entity valued at nearly $400 billion, according to the Financial Times [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

qz
Senior source denied AstraZeneca and Bristol Myers Squibb were ever in merger talks

A source close to the matter told Reuters there is "no deal" and there "never was a deal to be done" between the two drugmakers [...]

Match Score: 106.76

qz
Bristol Myers Squibb is striking a $15 billion drug licensing deal with China's Hengrui Pharma

The agreement covers 13 early-stage programs in oncology, hematology, and immunology, with $600 million due upfront [...]

Match Score: 66.78

qz
Bristol-Myers Squibb is bringing Anthropic's Claude to 30,000 employees

The biopharma company will use the AI model across research, drug development, manufacturing, and commercial and medical affairs [...]

Match Score: 66.78

qz
Bristol Myers Squibb is deploying NVIDIA's most powerful AI computing system to speed drug discovery

The drugmaker will deploy NVIDIA's Vera Rubin systems, giving it what it calls the most powerful AI computing infrastructure in life sciences [...]

Match Score: 66.78

qz
Bristol Myers Squibb is raising its full-year outlook after blood thinner sales surged past expectations

Strong sales of blood thinner Eliquis and newer drugs Camzyos and Reblozyl pushed second-quarter revenue to $12.97 billion, above analyst estimates [...]

Match Score: 66.78

qz
Bristol Myers Squibb is building a $2.3 billion drug manufacturing campus in Houston

The roughly 600,000-square-foot facility at Generation Park will create nearly 500 permanent jobs and about 2,000 construction positions [...]

Match Score: 66.78

qz
Appeals court revived a $6.7 billion lawsuit against Bristol Myers Squibb over delayed drug approvals

A unanimous 3-judge panel ruled that UMB Bank had standing to represent former Celgene shareholders despite a procedural error in its appointment [...]

Match Score: 66.78

Destination
Nissan announces its CEO will step down just one month after failed merger talks with Honda

Nissan CEO Makoto Uchida is stepping down on April 1, the company just announced. He will be replaced by acting Chief Planning Officer (CPO) Ivan Espinosa. Uchida has been CEO since 2019 and Espinosaâ [...]

Match Score: 49.43

Destination
Teamsters urge DOJ to block Paramount's Warner Bros. merger

The International Brotherhood of Teamsters, the union that covers warehouse workers, drivers and a diverse collection of other laborers, has come out against Paramount Skydance's merger with Warn [...]

Match Score: 49.42